OriGene Technologies Inc. announced the acquisition of Marligen Biosciences Inc., a provider of cutting-edge multiplex assays for the Luminex xMAP platform for protein and gene expression profiling assays and testing services, and DNA and RNA purification kits.
In a move aimed at creating a global presence in the protein analysis market—with solutions that will range in cost from $5,000 to $200,000—Cell Biosciences Inc. announced in September its acquisition of Alpha Innotech Corp.
Phenomenex Inc. has introduced Kinetex, ultra-high performance LC columns based on the company’s new core-shell silica technology. Kinetex meets researchers’ need to improve results and increase productivity without large capital expenditures.
Therapeutic antibodies have changed the cancer treatment landscape over the past decade. Both in liquid and solid tumors, antibodies have become an integral component of treatment regimens that have improved and extended the lives of cancer patients.
How do you know the government is upset about spending all its money on healthcare? When you’re required to pay a record $2.3 billion civil and criminal penalty over unlawful prescription drug promotions.
I can’t help but wonder what sort of opportunities could be created if the citizens, industry and lawmakers in struggling states such as my own worked together to replicate North Carolina’s success story.